Nutriband Inc. (NTRB) News
Follow Nutriband Inc. (NTRB) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 6 public stories across 6 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.
L
Nutriband Raises $1.75 Million From Warrant Exercises
Nutriband raised $1.75 million as 272,671 NTRBW warrants were exercised at $6.43. The warrants expired Sept. 30 without an extension, leaving no remaining tradeable warrants. Proceeds will fund AVERSA Fentanyl clinical w
EQUITY | Oct 13, 2026, 12:08 PM UTC
L
Nutriband CEO Gareth Sheridan Featured in New Nick Shirley Documentary Confronting America's Opioid Crisis
Sheridan joins independent journalist Nick Shirley to discuss how Nutriband's AVERSA™ abuse-deterrent technology is designed to help reduce the abuse, misuse, and accidental exposure driving the ongoing epidemicORLANDO,
NEWS | Sep 29, 2026, 01:28 PM UTC
L
Nutriband Appoints Decorated Navy SEAL and Veterans Health Advocate Robert J. O'Neill to Advisory Board
ORLANDO, Fla., Sept. 25, 2026 (GLOBE NEWSWIRE) -- Nutriband Inc. NASDAQ:NTRB NASDAQ:NTRBW today announced the appointment of Robert J. O'Neill to its Advisory Board. O'Neill is a highly decorated former U.S. Navy SEAL, N
NEWS | Sep 25, 2026, 12:08 PM UTC
L
NutriBand warrants to expire and be removed from Nasdaq listing on Sept. 30, 2026
NutriBand announced that its publicly traded warrants (NTRBW) will expire at 5:00 p.m. ET on September 30, 2026.Key Highlights:Original SEC Filing: NutriBand Inc. [ NTRB ] - 8-K - Sep. 23, 2026This is an AI-powered summa
REGULATION | Sep 23, 2026, 09:34 PM UTC
L
Nutriband receives USPTO notice for fentanyl patch brand trademarks
Nutriband received a USPTO Notice of Publication for commercial brand name trademarks covering its abuse-deterrent fentanyl transdermal system. If allowed, it plans to submit the commercial worldwide brand name to the FD
REGULATION | Sep 08, 2026, 01:07 PM UTC
L
NutriBand reports 3Q 2026 revenue $437,514, EPS $(0.07)
NutriBand reported third-quarter 2026 revenue of $437,514 and a net loss attributable to common stockholders of $(880,561), or diluted EPS of $(0.07).
EARNINGS | Sep 04, 2026, 08:42 PM UTC